In 2010, we formally demonstrated ADE by developing a mouse mode of ADE - mediated disease, and we began to dissect the contribution of humoral vs. cellular immune components in dengue vaccine - mediated protection using model vaccine candidates as tools to probe the mechanisms by which the vaccine -
induced immune responses in mice contribute to protection vs. ADE.
A key moment in her research occurred when she discovered that she could
induce an immune response in mice by injecting them with an irradiated malaria parasite.
Not exact matches
To find out, the team genetically modified
mice to block production of Nppb
in TRPV1 neurons, then injected the skin on their shoulders with a range of itch -
inducing compounds, including histamine, an inflammatory molecule involved
in immune responses, and the malaria drug chloroquine.
A recent study published
in Cell revealed that, while the related parasite Tritrichomonas musculis makes the intestine susceptible to both colitis and colorectal cancer, it
induces an
immune response that protects
mice against Salmonella infection.
The researchers found that
in mice, a single injection of 30 millionths of a gram of these mRNAs — a small fraction of the dose used for a typical vaccine —
induced a rapid
immune response, which protected
mice from intravenous exposure to a separate Zika strain two weeks later.
We find that a single administration of the MN patch
induces robust
immune responses in a B16F10
mouse melanoma model compared to MN without degradation trigger or intratumoral injection of free aPD1 with the same dose.
Through this approach, she showed
in mice that vaccine -
induced immune responses — which correlated with predicted MHC binding affinity and the measured peptide - MHC complex stability — were associated with positive outcomes.